Provided by Tiger Fintech (Singapore) Pte. Ltd.

Elanco Animal Health Inc

21.32
0.0000
Volume:- -
Turnover:- -
Market Cap:8.50B
PE:118.44
High:21.32
Open:21.32
Low:21.32
Close:21.32
52wk High:45.08
52wk Low:17.98
Shares:398.80M
Float Shares:398.16M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.1800
EPS(LYR):0.1840
ROE:1.26%
ROA:2.58%
PB:1.53
PE(LYR):115.86

Loading ...

Company Profile

Company Name:
Elanco Animal Health Inc
Exchange:
NYSE
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.